Visualizing the Role of the Complement Pathway in Paroxysmal Nocturnal Hemoglobinuria

Release Date: January 7, 2026

Expiration Date: January 7, 2027

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in paroxysmal nocturnal hemoglobinuria (PNH). In this educational program, these experts engage in an in-depth exploration of PNH, with a focus on pathophysiology and disease burden, clinical manifestations, best practices for timely and accurate identification, and the evolving treatment landscape, including updates on current standards of care, novel complement inhibitors, and emerging therapeutic strategies.

This educational activity is an archive of the live symposium held on December 5, 2025.

Target Audience

This educational activity is directed toward hematologists, hematologist-oncologists, nurse practitioners, physician assistants, primary care physicians, and other clinicians involved in the management of patients with PNH.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

• Apply strategies to diagnose patients with PNH
• Identify pathophysiological processes that provide therapeutic targets for PNH
• Analyze clinical trial data for therapies for PNH
• Design individualized management plans for patients with PNH using shared decision-making principles